110 related articles for article (PubMed ID: 35779823)
21. Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Pinyopornpanish K; Al-Yaman W; Butler RS; Carey W; McCullough A; Romero-Marrero C
Am J Gastroenterol; 2021 Nov; 116(11):2258-2269. PubMed ID: 34212895
[TBL] [Abstract][Full Text] [Related]
22. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
[TBL] [Abstract][Full Text] [Related]
23. Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
Kaplan DE; Serper MA; Mehta R; Fox R; John B; Aytaman A; Baytarian M; Hunt K; Albrecht J; Njei B; Taddei TH;
Gastroenterology; 2019 May; 156(6):1693-1706.e12. PubMed ID: 30660733
[TBL] [Abstract][Full Text] [Related]
24. Impact of statin use on the prognosis of patients with hepatocellular carcinoma undergoing liver resection: a subgroup analysis of patients without chronic hepatitis viral infection.
Nishio T; Taura K; Nakamura N; Seo S; Yasuchika K; Kaido T; Okajima H; Hatano E; Uemoto S
Surgery; 2018 Feb; 163(2):264-269. PubMed ID: 29167018
[TBL] [Abstract][Full Text] [Related]
25. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
26. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
[TBL] [Abstract][Full Text] [Related]
27. Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis.
Kaplan DE; Serper M; John BV; Tessiatore KM; Lerer R; Mehta R; Fox R; Aytaman A; Baytarian M; Hunt K; Albrecht J; Taddei TH;
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2148-2160.e14. PubMed ID: 32798709
[TBL] [Abstract][Full Text] [Related]
28. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.
Wong YJ; Qiu TY; Ng GK; Zheng Q; Teo EK
J Clin Gastroenterol; 2021 Aug; 55(7):615-623. PubMed ID: 33606427
[TBL] [Abstract][Full Text] [Related]
30. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis.
Antwi SO; Li Z; Mody K; Roberts LR; Patel T
J Clin Gastroenterol; 2020; 54(5):468-476. PubMed ID: 32271517
[TBL] [Abstract][Full Text] [Related]
31. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
[TBL] [Abstract][Full Text] [Related]
32. Statin use and lower extremity amputation risk in nonelderly diabetic patients.
Sohn MW; Meadows JL; Oh EH; Budiman-Mak E; Lee TA; Stone NJ; Pearce WB
J Vasc Surg; 2013 Dec; 58(6):1578-1585.e1. PubMed ID: 23932803
[TBL] [Abstract][Full Text] [Related]
33. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.
Mansi I; Frei CR; Wang CP; Mortensen EM
J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657
[TBL] [Abstract][Full Text] [Related]
34. Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study.
Kristensen FP; Christensen DH; Callaghan BC; Kahlert J; Knudsen ST; Sindrup SH; Feldman EL; Østergaard L; Andersen H; Jensen TS; Sørensen HT; Thomsen RW
Diabetes Care; 2020 Dec; 43(12):2945-2952. PubMed ID: 32998990
[TBL] [Abstract][Full Text] [Related]
35. Statin Use and Survival with Early-Stage Hepatocellular Carcinoma.
Jeon CY; Goodman MT; Cook-Wiens G; Sundaram V
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):686-92. PubMed ID: 26908429
[TBL] [Abstract][Full Text] [Related]
36. Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients.
Wu LL; Hsieh MC; Chow JM; Liu SH; Chang CL; Wu SY
Medicine (Baltimore); 2016 Sep; 95(36):e4639. PubMed ID: 27603355
[TBL] [Abstract][Full Text] [Related]
37. Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes.
Yang X; Wang Y; Luk AO; So WY; Ma RC; Kong AP; Xu G; Chan JC
Endocr Relat Cancer; 2013 Apr; 20(2):161-71. PubMed ID: 23250907
[TBL] [Abstract][Full Text] [Related]
38. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
[TBL] [Abstract][Full Text] [Related]
39. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.
Ooba N; Setoguchi S; Sato T; Kubota K
BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223
[TBL] [Abstract][Full Text] [Related]
40. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
